Outset Medical Raises Financing, Looks to Expand Settings for Tablo Use

Restricted access

Outset Medical (San Jose, CA) recently completed another round of financing, raising $132 million in Series D equity financing to help accelerate production and commercial expansion of the Tablo Hemodialysis System.

The lead investor in this round of financing was Mubadala Investment Company of Abu Dhabi. Other participating investors in Outset Medical, which launched in 2010, include Baxter Ventures, Fidelity Research and Management, and Warburg Pincus, an early investor.

Featuring real-time water purification and dialysis fluid production in a compact system on wheels, the Tablo dialysis technology can meet patients’ needs at home, in hospitals, and in dialysis centers, Outset

Save